Sees FY23 R&D expense in the range of $235M to $255M, which includes approximately $20M of stock-based compensation expense and SG&A expense in the range of $360M to $380M, which includes approximately $45M of stock-based compensation expense.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ACAD:
